These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30626910)

  • 1. How elusive can a malaria vaccine be?
    Pance A
    Nat Rev Microbiol; 2019 Mar; 17(3):129. PubMed ID: 30626910
    [No Abstract]   [Full Text] [Related]  

  • 2. First DNA malaria vaccine on trial in Africa.
    Ferry G
    Curr Biol; 2000 Nov; 10(22):R810-1. PubMed ID: 11102816
    [No Abstract]   [Full Text] [Related]  

  • 3. The development of a multivalent DNA vaccine for malaria.
    Hedstrom RC; Doolan DL; Wang R; Gardner MJ; Kumar A; Sedegah M; Gramzinski RA; Sacci JB; Charoenvit Y; Weiss WR; Margalith M; Norman JA; Hobart P; Hoffman SL
    Springer Semin Immunopathol; 1997; 19(2):147-59. PubMed ID: 9406343
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.
    Longley RJ; Halbroth BR; Salman AM; Ewer KJ; Hodgson SH; Janse CJ; Khan SM; Hill AVS; Spencer AJ
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
    Ballou WR; Kester KE; Heppner DG
    Chem Immunol; 2002; 80():253-61. PubMed ID: 12058643
    [No Abstract]   [Full Text] [Related]  

  • 6. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
    Saul A
    J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of transgenic parasites in malaria vaccine research.
    Othman AS; Marin-Mogollon C; Salman AM; Franke-Fayard BM; Janse CJ; Khan SM
    Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria DNA vaccines in Aotus monkeys.
    Gramzinski RA; Maris DC; Doolan D; Charoenvit Y; Obaldia N; Rossan R; Sedegah M; Wang R; Hobart P; Margalith M; Hoffman S
    Vaccine; 1997 Jun; 15(8):913-5. PubMed ID: 9234546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.
    Narum DL; Kumar S; Rogers WO; Fuhrmann SR; Liang H; Oakley M; Taye A; Sim BK; Hoffman SL
    Infect Immun; 2001 Dec; 69(12):7250-3. PubMed ID: 11705894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A malaria vaccine based on a sporozoite antigen.
    Nussenzweig RS; Zavala F
    N Engl J Med; 1997 Jan; 336(2):128-30. PubMed ID: 8988893
    [No Abstract]   [Full Text] [Related]  

  • 11. Pfs230: from malaria transmission-blocking vaccine candidate toward function.
    Williamson KC
    Parasite Immunol; 2003 Jul; 25(7):351-9. PubMed ID: 14521577
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons.
    Kumar R; Nyakundi R; Kariuki T; Ozwara H; Nyamongo O; Mlambo G; Ellefsen B; Hannaman D; Kumar N
    Vaccine; 2013 Jun; 31(31):3140-7. PubMed ID: 23684840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
    Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
    Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The promise of asexual malaria vaccine development.
    Pasloske BL; Howard RJ
    Am J Trop Med Hyg; 1994; 50(4 Suppl):3-10. PubMed ID: 8172329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinating with the genome: a Sisyphean task?
    Coppel RL
    Trends Parasitol; 2009 May; 25(5):205-12. PubMed ID: 19359219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant protein vaccines against the asexual blood stages of Plasmodium falciparum.
    Anders RF; Adda CG; Foley M; Norton RS
    Hum Vaccin; 2010 Jan; 6(1):39-53. PubMed ID: 20061790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies and Plasmodium falciparum merozoites.
    Ramasamy R; Ramasamy M; Yasawardena S
    Trends Parasitol; 2001 Apr; 17(4):194-7. PubMed ID: 11282510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.
    Hoffman SL; Doolan DL; Sedegah M; Aguiar JC; Wang R; Malik A; Gramzinski RA; Weiss WR; Hobart P; Norman JA; Margalith M; Hedstrom RC
    Vaccine; 1997 Jun; 15(8):842-5. PubMed ID: 9234529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The naturally acquired immunity in severe malaria and its implication for a PfEMP-1 based vaccine.
    Chen Q
    Microbes Infect; 2007 May; 9(6):777-83. PubMed ID: 17398133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.